Moderna
MRNA
#1830
Rank
ยฃ8.12 B
Marketcap
ยฃ20.79
Share price
8.67%
Change (1 day)
-38.21%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Revenue for Moderna (MRNA)

Revenue in 2025 (TTM): ยฃ1.68 Billion

According to Moderna 's latest financial reports the company's current revenue (TTM ) is ยฃ1.65 Billion. In 2024 the company made a revenue of ยฃ2.54 Billion a decrease over the revenue in the year 2023 that were of ยฃ5.30 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Moderna from 2018 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ1.68 B-33.71%
2024 ยฃ2.54 B-51.91%
2023 ยฃ5.30 B-66.02%
2022 ยฃ15.60 B18.74%
2021 ยฃ13.13 B6427.5%
2020 ยฃ0.20 B449.5%
2019 ยฃ36.63 M-62.12%
2018 ยฃ96.71 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Regulus Therapeutics
RGLS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.21 B 2,817.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
ยฃ0.06 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ2.40 B 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ42.31 B 2,460.04%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Arrowhead Pharmaceuticals
ARWR
ยฃ0.43 B-73.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ69.17 B 4,084.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
ยฃ0.14 B-91.24%๐Ÿ‡บ๐Ÿ‡ธ USA